Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total revenue	$ 76,874	$ 53,303	$ 209,810	$ 145,148
Cost of services	29,045	28,044	81,618	85,896
Gross profit	47,829	25,259	128,192	59,252
Research and development	11,665	14,288	34,134	46,018
Selling and marketing	17,025	16,763	49,695	45,397
General and administrative	26,145	26,099	73,760	107,129
Impairment loss	0	8,282	0	10,402
Other operating expenses, net	774	2,794	2,622	5,259
Loss from operations	(7,780)	(42,967)	(32,019)	(154,953)
Non-operating income (expenses), net
Change in fair value of warrants and earn-out contingent liabilities	(880)	590	(11,390)	684
Interest (expense) income, net	(843)	1,053	(2,334)	2,092
Other income (expense), net	1,144	(1,134)	(12,300)	1,668
Total non-operating income (expense), net	(579)	509	(26,024)	4,444
Loss before income taxes	(8,359)	(42,458)	(58,043)	(150,509)
Income tax benefit	47	172	319	515
Net loss	(8,312)	(42,286)	(57,724)	(149,994)
Other comprehensive loss, net of tax
Unrealized gain related to available for sale securities, net	459	0	493	0
Comprehensive loss	$ (7,853)	$ (42,286)	$ (57,231)	$ (149,994)
Weighted average shares outstanding of Class A common stock, Basic (in shares)	27,095,986	25,788,747	26,593,877	23,777,327
Weighted average shares outstanding of Class A common stock, Diluted (in shares)	27,095,986	25,788,747	26,593,877	23,777,327
Basic net loss per share, Class A common stock (in dollars per share)	$ (0.31)	$ (1.64)	$ (2.17)	$ (6.31)
Diluted net loss per share, Class A common stock (in dollars per share)	$ (0.31)	$ (1.64)	$ (2.17)	$ (6.31)
Class A common stock
Other comprehensive loss, net of tax
Weighted average shares outstanding of Class A common stock, Basic (in shares)	27,095,986	25,788,747	26,593,877	23,777,327
Weighted average shares outstanding of Class A common stock, Diluted (in shares)	27,095,986	25,788,747	26,593,877	23,777,327
Basic net loss per share, Class A common stock (in dollars per share)	$ (0.31)	$ (1.64)	$ (2.17)	$ (6.31)
Diluted net loss per share, Class A common stock (in dollars per share)	$ (0.31)	$ (1.64)	$ (2.17)	$ (6.31)
Diagnostic test revenue
Total revenue	$ 77,418	$ 51,955	$ 207,961	$ 140,440
Other revenue
Total revenue	$ (544)	$ 1,348	$ 1,849	$ 4,708